Patients with chronic pancreatitis have a 26-fold higher risk for developing pancreatic cancer compared to the general population (Lowenfels et al., 1993; Kirkegard et al., 2017), suggesting that CFTR mutation could be considered as a new risk factor for developing PDAC. Here, CFTR is linked to pancreatic neoplasm.